R. ÖZARAS Et Al. , "Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis," The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , vol.1, Tokyo, Japan, pp.1, 2016
ÖZARAS, R. Et Al. 2016. Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis. The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , (Tokyo, Japan), 1.
ÖZARAS, R., METE, B., YEMİŞEN, M., Balkan, I. I., ALkan, M., & Tabak, F., (2016). Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis . The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL) (pp.1). Tokyo, Japan
ÖZARAS, Reşat Et Al. "Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis," The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Tokyo, Japan, 2016
ÖZARAS, Reşat Et Al. "Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis." The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , Tokyo, Japan, pp.1, 2016
ÖZARAS, R. Et Al. (2016) . "Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis." The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL) , Tokyo, Japan, p.1.
@conferencepaper{conferencepaper, author={Reşat ÖZARAS Et Al. }, title={Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis}, congress name={The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL)}, city={Tokyo}, country={Japan}, year={2016}, pages={1} }